Cargando…
Medication adversely impacts visually-guided eye movements in Parkinson’s disease
OBJECTIVE: We examined whether previous inconsistent findings about the effect of anti-Parkinsonian medication on visually-guided saccades (VGS) were due to the use of different paradigms, which change the timing of fixation offset and target onset, or different target eccentricities. METHODS: Thirt...
Autores principales: | Munoz, Miranda J., Reilly, James L., Pal, Gian D., Metman, Leo Verhagen, Rivera, Yessenia M., Drane, Quentin H., Corcos, Daniel M., David, Fabian J., Goelz, Lisa C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193957/ https://www.ncbi.nlm.nih.gov/pubmed/35995722 http://dx.doi.org/10.1016/j.clinph.2022.07.505 |
Ejemplares similares
-
Medication only improves limb movements while deep brain stimulation improves eye and limb movements during visually-guided reaching in Parkinson’s disease
por: Munoz, Miranda J., et al.
Publicado: (2023) -
Encoding type, medication, and deep brain stimulation differentially affect memory-guided sequential reaching movements in Parkinson's disease
por: David, Fabian J., et al.
Publicado: (2022) -
The Effects of Subthalamic Nucleus Deep Brain Stimulation and Retention Delay on Memory-Guided Reaching Performance in People with Parkinson’s Disease
por: Trevarrow, Michael P., et al.
Publicado: (2023) -
Subthalamic Peak Beta Ratio Is Asymmetric in Glucocerebrosidase Mutation Carriers With Parkinson's Disease: A Pilot Study
por: David, Fabian J., et al.
Publicado: (2021) -
A Novel Dual-Frequency Deep Brain Stimulation Paradigm for Parkinson’s Disease
por: Karl, Jessica A., et al.
Publicado: (2019)